Table 5.
Organizations regulating and coordinating nanomedical translational work
| EMA | European Medicines Agency | https://www.ema.europa.eu/ |
| ETPN | European Technology Platform for Nanomedicine: established the first European Translational Advisory Board | https://etp-nanomedicine.eu/ |
| ERC | European Research Council | https://erc.europa.eu/ |
| FDA | US Food & Drug Administration | https://www.fda.gov/ |
| NNI | National Nanotechnology Initiative | https://www.nano.gov/ |
| Health Canada | Health Canada | https://www.canada.ca/en/health-canada.html |
| NINT | National Institute for Nanotechnology | http://www.nint-innt.ca/ |
| PMDA | Pharmaceuticals and Medical Devices Agency | https://www.pmda.go.jp/english/ |
| JST | Japan Science and Technology Agency | https://www.jst.go.jp/EN/ |
| TGA | Therapeutic Goods Administration; Australian Government Departmen of Health | https://www.tga.gov.au/ |
| ANN | Australian Nanotechnology Network | http://www.ausnano.net/ |
| CFDA | China Food and Drug Administration | http://eng.sfda.gov.cn/ |
| NanoCTR | National Center for Nanoscience and Technology | http://english.nanoctr.cas.cn/ |